Details for Patent: 8,496,965

Summary for Patent: 8,496,965

Title:	Pellet formulation for the treatment of the intenstinal tract
Abstract:	An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically tolerable salt or a derivative thereof.
Inventor(s):	Otterbeck; Norbert (Uberlingen, DE)
Assignee:	Dr. Falk Pharma GmbH (Freiburg, DE)
Application Number:	13/586,585
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,496,965
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 8,496,965

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 8,496,965

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	197 32 903	Jul 30, 1997

International Family Members for US Patent 8,496,965

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	241964
Canada	2297832
Germany	19732903
Germany	59808642